Zurueck zur Suche

Reporte zur Charge UJ483AB

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

2Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
UT 1 IA 1

VAERS 2720064

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ483AB

gering
Staat
UT
Alter
72,0
Geschlecht
F
Eingang
01.12.2023
Impfdatum
17.10.2020
Beginn
18.10.2020
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Shoulder injury related to vaccine administration

Symptomtext

Patient reports a vaccine administration related shoulder injury.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Shoulder injury related to vaccine administration
Hospital-Tage
-
Labordaten
unknown
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 1756430

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ483AB

gering
Staat
IA
Alter
71,0
Geschlecht
M
Eingang
02.10.2021
Impfdatum
22.09.2021
Beginn
22.09.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

A patient was administered with an expired dose of FLUZONE HIGH-DOSE QUADRIVALENT with no reported AE; Initial information regarding an unsolicited valid non-serious case was received from other health professional via consumer/non-health care professional via Medical Information (Reference number- 00784366) and transmitted to Sanofi on 24-Sep-2021. This case involves a 71-year-old male patient who was administered with an expired INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT] (Expired product administered). Medical history, medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided. On 22-Sep-2021, the patient received a 0.7 ml dose of suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE (lot UJ483AB, expiry: 30-Jun-2021, formulation: solution for injection in pre-filled syringe) via intramuscular route in the right deltoid for prophylactic vaccination. It was a case of an actual medication error due to Expired vaccine used (latency same day). No adverse event was reported. It was reported "Caller stated that her office started giving this seasons FLUZONE high dose (HD) vaccines but a vaccine from last season was given of the 2020-2021 FLUZONE HD and she would like to know if the patients need to be revaccinated or what the process is now? Caller states Fluzone HD was given from last season, expired dose. She asks for follow-up. She clarifies, so it can be given again immediately." This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-